Literature DB >> 5470429

Correlation of subjective side effects with plasma concentrations of nortriptyline.

M Asberg, B Cronholm, F Sjöqvist, D Tuck.   

Abstract

Plasma levels of tricyclic antidepressant drugs vary considerably between individuals receiving the same amount of drug. The bearing of this variation on the occurrence of subjective side effects was investigated in 40 psychiatric inpatients with depressive disorders. Plasma levels were determined before and during four weeks of treatment with nortriptyline 50 mg. three times a day and patients were rated for subjective side effects, the assessors being unaware of the plasma levels of the drug.Plasma levels varied widely between individual patients, but in any given patient the plasma level tended to be constant over a period of time. The side effects of nortriptyline diminished significantly with time and were in most cases absent during the fourth week of treatment. There was a significant positive correlation between plasma level of nortriptyline and subjective side effects.The steady-state plasma level of a drug which is metabolized is usually a more important determinant for its effect than dosage, since it reflects the amount of drug available for biological action. Very high plasma levels of nortriptyline should presumably be avoided, since there is no evidence that they are needed for therapeutic effect and they are potentially harmful.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5470429      PMCID: PMC1820531          DOI: 10.1136/bmj.4.5726.18

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  PRE-EXISTING CONDITIONS, PLACEBO REACTIONS, AND "SIDE EFFECTS".

Authors:  D M GREEN
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

2.  The experience of memory function after electroconvulsive therapy.

Authors:  B CRONHOLM; J O OTTOSSON
Journal:  Br J Psychiatry       Date:  1963-03       Impact factor: 9.319

3.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

4.  Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.

Authors:  W M Hammer; B B Brodiet
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

5.  A comparative trial of desipramine and nortriptyline in depression.

Authors:  J A Stewart; P H Mitchell
Journal:  Br J Psychiatry       Date:  1968-04       Impact factor: 9.319

6.  The pathology of a cross-over trial: (thiazesim--a new anti-depressant drug).

Authors:  R Berry; P Turner
Journal:  Br J Psychiatry       Date:  1968-02       Impact factor: 9.319

7.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

8.  A comparison of nortriptyline and amitriptyline in depression.

Authors:  J T Rose; M R Leahy; I C Martin; T T Westhead
Journal:  Br J Psychiatry       Date:  1965-11       Impact factor: 9.319

9.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27

Review 10.  Biogenic amines and emotion.

Authors:  J J Schildkraut; S S Kety
Journal:  Science       Date:  1967-04-07       Impact factor: 47.728

  10 in total
  44 in total

1.  The relationship between nortriptyline plasms levels and clinical effects.

Authors:  P Kragh-Sorensen
Journal:  Proc R Soc Med       Date:  1975-02

2.  Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart.

Authors:  N Barth; M Manns; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  The assessment of potential drug interactions with a new tricyclic antidepressant drug.

Authors:  R H Briant; C F George
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

4.  Plasma concentrations of tricyclic antidepressive drugs.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

5.  Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans.

Authors:  Anne Germain; Robin Richardson; Douglas E Moul; Oommen Mammen; Gretchen Haas; Steven D Forman; Noelle Rode; Amy Begley; Eric A Nofzinger
Journal:  J Psychosom Res       Date:  2011-12-20       Impact factor: 3.006

6.  Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.

Authors:  M E Mooney; V I Reus; J Gorecki; S M Hall; G L Humfleet; R F Muñoz; K Delucchi
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875

7.  A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

8.  Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.

Authors:  L Bjerkenstedt; L Flyckt; K F Overø; O Lingjaerde
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Cimetidine-induced alterations in desipramine plasma concentrations.

Authors:  J D Amsterdam; D J Brunswick; L Potter; M J Kaplan
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 10.  Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

Authors:  Christoph Hiemke
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.